GUL KHAN: Open Payments
NPI 1962894659 · FLORAL PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 14 payments from 5 companies in 2025. Trend: 2023 $276 · 2024 $25 · 2025 $907
Long term medical supply or device loan: $698Food & beverage: $131Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $716 |
| Janssen Biotech, Inc. | 1 | $78 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| GENZYME CORPORATION | 1 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
Products named: KISQALI, RYBREVANT, OJJAARA, WAYRILZ, FUROSCIX, BLENREP.
Industry payments across NY — which companies pay providers there.
